norm: amarin pharmaUSLEI 549300MKT6IIF5E7CZ52 · no CIKMax severity: Low↳ subsidiary of AMARIN CORP PLC\UK

Canonical registry

Amarin Pharma, Inc.

ent_019ec0600c0a229045422d6dc442a86d

Compliance scorecard →🔔 Follow entity

Disclosures

1

State AG · 1 jurisdiction

Incidents

—

no linked incident in sample

Max affected reported

—

no filed count in sample

Leak-site claims

0

none in sample

Identity resolution

Canonical name: Amarin Pharma, Inc.
Normalized: amarin pharma— dedupe via name-norm; Microsoft / MSFT collapse to one row
GLEIF LEI: 549300MKT6IIF5E7CZ52
SEC EDGAR CIK: None — not an SEC registrant
Domain: None on record
Corporate parent: AMARIN CORP PLC\UK— per SEC Exhibit 21 filing

Disclosure history (1)newest first

🐻California State AGas victim2019-08-05
Amarin Pharma, Inc. reported a data breach involving a third-party vendor's database containing consumer information for its Vascepa copay program. The breach resulted from a database misconfiguration allowing unauthorized access between May 2, 2018, and June 20, 2019. Affected data included names, addresses, phone numbers, and medication interest data. No financial or SSN data was involved. Amarin suspended data feeds and took the database offline, engaging forensic investigators.